![[Featured Stock] Remedy Plunges 21% on Second Day of Listing Amid Profit-Taking](https://f1.tokenpost.kr/2026/07/iq2ttzep45.jpg)
[Featured Stock] Remedy Plunges 21% on Second Day of Listing Amid Profit-Taking
Remedy is experiencing a sharp decline on the second day of its KOSDAQ listing. Following a trading close above its IPO price on the first day, profit-taking has emerged, coupled with a general contraction in investor sentiment in the KOSDAQ market, leading to a significant drop in its stock price.
Key takeaway
"[Featured Stock] Remedy Plunges 21% on Second Day of Listing Amid Profit-Taking" — BullBear's AI rates this story as a bearish (negative) signal for markets, with a market-impact score of 40 out of 100. Remedy is experiencing a sharp decline on the second day of its KOSDAQ listing. Following a trading close above its IPO price on the first day, profit-taking has emerged, coupled with a general contraction in investor sentiment in the KOSDAQ market, leading to a significant drop in its stock price. Reported by TokenPost on July 14, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Catch the next bear flag
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 48.9%.
